Комплексная терапия больных с невротическими расстройствами с использованием иммуномодуляторов миелопептидной природы
Диссертация
Эффективность сочетанной терапии психотропными препаратами и иммуномодулятором больных со смешанным тревожным и депрессивным расстройством превосходит результат назначения традиционной психофармакотерапии и монотерапии в отдельности. a. — редукция психопатологической симптоматики наступает быстрее при присоединении иммуномодулятора к традиционной психофармакотерапии, а так же возрастает… Читать ещё >
Список литературы
- Авруцкий Г. Я., Недува А. А. Лечение психически больных. М.: Медицина, 1988. — 528 с.
- Авруцкий Г. Я Авруцкий Г. Я., Гурович И. Я., Громова В. В., Фармакотера-пия психических заболеваний, М., 1974-
- Адо А. Д. Общая аллергология. Л., Наука, 1985
- Александровский Ю.А. Клиническая фармакология транквилизаторов. М.: Медицина, 1973. — стр.336.
- Александровский Ю.А. Начальные проявления невротических расстройств //Клиническая медицина, 1988 г., № 9 стр.58−65.
- Александровский Ю.А. Пограничные нервно-психические расстройства. М. Медицина 2000 г.
- Александровский Ю.А. Состояния психической дезадаптации и их компенсация. М.: Наука, 1976 г., стр. 272.
- Александровский Ю.А. Состояния психической дезадаптации и их компенсация. М.: Наука, 1976 г., стр. 312.
- Александровский Ю.А., Аведисова А. С., Серебрякова Т. В. Некоторые особенности действия современных гипнотиков. Расстройства сна/под ред. А. М. Вейн. СПб.: Мединформационное агентство, 1995. -стр.44−56.
- Александровский Ю.А., Лобастов О. С., Спивак Л. И., Щукин Б. П. Психогении в экстремальных условиях М.: Медицина, 1991 г., стр. 96.
- Александровский ЮА., Новиков М. А. Принципы психопрофилактики и коррекции психологических состояний // Человек в космическом полете. М.: Наука, 1997. — Т.1П, кн.2, гл. 20. — стр.269−290.
- Андросова В. В. Инсомния при невротических расстройствах: фармакотерапевтический анализ действия гипнотиков.// Российский психиатрический журнал № 1 2004
- Березин В.А., Белик Я. В. Специфические белки нервной ткани.// Киев 1990.
- Бутома Б.Г., Васильева О. А., Ариненко М. Ю., Аникин В. Б. интерфероновый профиль больных шизофренией, резистентных к психофармакотерапии, и их родствеников/ЛОбилейная X Конференция «Нейроиммунология» ТОМ 2, СТ. 49 (сс. 223−297) -28−31 мая 2001 г.
- Васильева О.А., Логвинович Г.В. XII съезд психиатров России: Материалы. М 1995- 289−290.
- Ветлугина Т.П., Семке В. Я. Клиническая психонейроиммунология на современном этапе. // Сибирский вестник психиатрии и наркологии. — 2001 г. № 3. — стр.34−36.
- Вилков Т. А., Коваленко В. М., Дубатова И. В., Страдомский Б. В., Межова JI. И. Механизмы «шоковых» методов лечения шизофрении // XII съезд психиатров России. — М.: Российское общество психиатров, 1995. С. 505−506.
- Вовин Р.Я., 1975 Вовин Р.Я. В кн.: Фармакотерапевтические основы реаби-литации психически больных. М., 1989- 10−35.
- Говорин Н. В., Злова Т. П., Кошмелева Я. А., Березкин А. С.// Российский психиатрический журнал № 6 — 2003
- Говорин Н.В. и соавт. Дифференцированная психофармакотерапия при ИБС. //Клиническая фармакология и терапия. 1997- 6.
- Голодец Р.Г., Сухотина Н. К. Журн. невропатол. и психиатр. 1988- 3: 413−7.
- Жане П. (Jannet Р.) Неврозы. Переводы с фран. М., «Космос», 1911 г., 1−315.
- Коркина М.В., Лакосина Н. Д., Личко А. Е. «Психиатрия», М.: Медицина, 1995 гг., стр.331−335.
- Коркина М.В., Лакосина Н. Д., Личко А. Е. «Психиатрия», М.: Медицина, 1995 гг., стр. 608.
- Краснов В.М. Экологическая психиатрия: методология, предмет исследования и ближайшие задачи // Материалы ХП съезда психиатров России. Москва. — 1995 г. — стр. 158−160.
- Крыжановский Г. Н. 1974 -2000 Крыжановский Г.Н. Дерминантные структу-ры в патологии нервной системы. М.: Медицина, 1980. 358 с.
- Крыжановский Г. Н. Стресс и иммунитет // Вестник АМН СССР.-1985.-№ 8.-С. 3−11.
- Крыжановский Г. Н. Общая патофизиология нервной системы.- М.: Медици-на, 1997.- 348с.
- Кутько И.И., Петрюк П. П. Крыжановский А.В. Циклотимические депрессии: клиника, лечение и предупреждение приступов. Киев -1995.
- Кутько И.И., Стефанов-ский В.А., Букреев В. И. и др.: Депрессивные расстройства. Киев- Здоровье, 1992.-156 с.-ISBN 5311−2 706−1.
- Машковский М. Д Лекарственные средства. Москва, «Медицина», 1993 г., Т.1.-стр.356−357.
- Международная классификация болезней (10-й пересмотр). Классификация психических и поведенческих расстройств. Россия, Санкт-Петербург, «АДИС», 1994 г., стр. 303.
- Миневич В.Б. Экологическая психиатрия: Необходимость формирования и перспективы развития нового направления в науке. Барнаул, 1991. — с. 18−23.
- Мирошниченко Л.Д., Пелипас В. Е. Наркологический энциклопедический словарь. М., 2002
- Мосолов С. Н Биологические основы современной антипсихотической те-рапии // Российский психиатрический журнал, 1998, N6, с. 712.
- Музыченко А.П. и др., 2002 Музыченко А. П., Морозов П. В., Каргальцев Д. А. и др. Иксел в клинической практике // Психиатрия и пихофармакотерапия.— 2000.— Т. 3.— № 3.— С. 611.
- Невидимова Т. И. Психонейроиммунные взаимоотношения в терапии эндогенных психозов и реактивных депрессивных состояний (клинико-экспериментальные исследования). Автореферат диссертации докт.мед.наук Томск, — 1997 г. — стр.40.
- Петров Р.В., Дуринян Р. А. Василенко A.M. Аналгезирующий эффект миело-пепти-дов. //Патолог, физиология и эксперимент, терапия.-1986, № 1.-с.13−15.
- Петров Р.В., Михайлов А. А., Захарова JI.A. Костномозговые медиаторы, ре-гулирующие иммунный ответ (миелопептидный)// Гематология и транфу-зиология 1990, № 8, с.7−10.
- Регистр лекарственных средств России. Энциклопедия лекарств. Издание 8. Под ред. Крылова Ю. Ф. Москва. — 2001 г. — стр.242.
- Семенов С.Ф., Попова Н. Н. Нервно-психические заболевания в свете иммунопатологии мозга. М 1969- 41−47.
- Секирина Т.П., Фокин В. Ф., Пономарева Н. В., Андросова Л. В., Коляскина Г. И., Новоселов В. М. Взаимосвязи между деятельностьюголовного мозга и иммунной системой у человека//Физиология человека.-1995.-Т.21, No2.-C. 15−23.
- Семке В.Я., Ветлугина Т. П., Невидимова Т. Н., Иванова С. А., БоханН.А. Клиническая психонейроиммунология. Томск, Издательство «Раско», 2003.
- Смулевич А.Б., Сыркин A.JI. и соавт. Органные неврозы как психосоматическая проблема. // Журнал неврологии и психиатрии имени С. С. Корсакова. 2000 г. — № 12. — стр.4−12.
- Темков И., Киров К., Клиническая психофармакология, пер. с болг., М., 1971-
- Фон Берталанфи JI. Общая теория систем. Обзор проблем и результатов. В кн.: Системные исследования. Ежегодник. М., Наука, 1969. 250 с.
- Хаитов Р.М., Игнатьева Г. А., Сидорович И. Г. Иммунология. М.: Медицина, 2000. — стр.432.
- Хаитов P.M., Пинегин Б. В., Истамов Х. И. Экологическая иммунология. -М.: Изд-во ВНИРО, 1995. стр. 219.
- Хаитов Р.М., Пинегин Б. В. Иммуномодуляторы: механизмы действия и клиническое применение // Аллергология и иммунология. 2000. -Т.1 -№ 2. -стр.8−9.
- Хаитов Р.М., Пинегин Б. В. Иммуномодуляторы и некоторые аспекты их клинического применения // Клиническая медицина. 1996. — № 8.-стр.7−12.
- Хаитов P.M., Пинегин Б. В. Основные представления об иммунотропных лекарственных средствах // Иммунология. 1996. — № 6. — стр.4−9.
- Чехонин, В. П. Иммунохимический анализ нейроспецифических антигенов/ В. П. Чехонин, Т. Б. Дмитриева, Ю. А. Жирков М.: Медицина, 1999 415,16.: а-ил. Библиогр.: 807 назв
- Штарк М.Б. 1986, Штарк М.Б., Береговой Н. А., Старостина М. В. и др. Базо-вые механизмы терапии психических расстройств сверхмалыми дозами ан-тител к мозгоспецифическому белку S-100. //Тез.докл.ХШ съезда психиат-ров России. М., — 2000, с. 374.
- Ader R., Psychoneuroimmunology Conditioning and Stress // Annual Review of psychology. 1994. Vol. 45. P.8.
- Ader R, Cohen N., Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system // Lancet. 1995. Vol. 345, № 8942. P.99−103.
- Ader R., Felten D., Cohen N. Interactions between the brain and the immune system // Annu. Rev. Pharmacol, and Toxicol. 1990. Vol. 30. P.561−602.
- Aloisi F., et al. Intracerebral regulation of immune responses //Ann Med.- 2001.- vol. 33, p. 510−515.
- Aloisi F., et al. Glia-T cell dialogue //J Neuroimmunol.- 2000.- vol. 107, p. 111−117.
- American Psychiatric Association: Diagnostic and Statistical Manual of Mentalth
- D. Sorders, 4 -ed. Washington D.C., American Psychiatric Association, 1994.
- Andreoli A., et al. Immunity, major depression, and panic disorder comorbidity //Biol Psychiatry.- 1992.- vol. 31, p. 896−908.
- Anisman H., Ravindran A.V., Griffiths J., Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features // J. Mol. Psychiatry. 1999. Vol. 4, № 2. P. 182−188.
- Angst J., Dobler-Mikola A. The Zurich Study. V. Anxiety and phobia in young adults //Eur Arch Psychiatry Neurol Sci.- 1985.- vol. 235, p. 171 178.
- Angst J., Dobler-Mikola A. The Zurich Study. VI. A continuum from depression to anxiety disor-ders? //Eur Arch Psychiatry Neurol Sci.-1985.- vol. 235, p. 179−186.
- Baker G.H. Psychological factors and immunity // J. Psychosom. Res. 1987. Vol. 31, № l.P.1−10.
- Baltuch G.H., et al. T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism //Neurosurgery.- 1994.-vol. 35, p. 450−456- discussion 456.
- E.N. Cytokine actions in the central nervous system //Cytokine Growth Factor Rev.- 1998.- vol. 9, p. 259−275.
- Benveniste E.N., et al. Immunological aspects of microglia: relevance to Alzheimer’s disease //Neurochem Int.- 2001.- vol. 39, p. 381−391.
- Benveniste E.N., et al. Molecular regulation of CD40 gene expression in macrophages and micro-glia //Brain Behav Immun.- 2004.- vol. 18, p. 7−12.
- Berkenbosch F. Macrophages and astroglial interactions in repair to brain injury //Ann N Y Acad Sci.- 1992.- vol. 650, p. 186−190.
- Besedovsky H.O. Psychoneuroimmunology: An Overview // Psychoneuroimmunology. N.-Y., 1992. P. 13−20.
- Billiau A., et al. Biologic role of interferon beta in multiple sclerosis //J Neurol.- 2004.- vol. 251 Suppl 2, p. 1110−14.
- Blatteis C.M., Sehic E. Cytokines and fever //Ann N Y Acad Sci.-1998.- vol. 840, p. 608−618.
- Blatteis C.M., et al. Pyrogen sensing and signaling: old views and new concepts //Clin Infect Dis.- 2000.- vol. 31 Suppl 5, p. S168−177.
- Bleuler M. Endokrinologische Psychiatric. Stuttgart, -1954.
- Blum A. Triad of hyperthermia, increased REM sleep, and cataplexy during clozapine treatment? //J Clin Psychiatry.- 1990.- vol. 51, p. 259 260.
- Bonnet J.J. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter //Eur J Pharmacol.- 2003.- vol. 479, p. 199−212.
- Brambilla F., et al. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: ef-fect of alprazolam therapy //Psychiatry Res.- 1999.- vol. 89, p. 21−27.
- Brambilla F., et al. Neurosteroid secretion in panic disorder //Psychiatry Res.- 2003.-vol. 118, p. 107−116.
- Brambilla F., et al. Interleukin-lbeta and tumor necrosis factor-alpha in children with major de-pressive disorder or dysthymia //J Affect Disord.- 2004.- vol. 78, p. 273−277.
- Calogero A.E., et al. Mechanisms of serotonin receptor agonist-induced activation of the hypotha-lamic-pituitary-adrenal axis in the rat //Endocrinology.- 1990.- vol. 126, p. 1888−1894.
- Cash E., Rott O. Microglial cells qualify as the stimulators of unprimed CD4+ and CD8+ T lym-phocytes in the central nervous system //Clin Exp Immunol.- 1994.- vol. 98, p. 313−318.
- Cazzullo C.L., et al. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study //Prog Neuropsychopharmacol Biol Psychiatry.- 2002.- vol. 26, p. 33−39.
- Cazzullo C.L., et al. Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients //Schizophr Res.- 1998.- vol. 31, p. 49−55.
- Cazzullo C.L., et al. Cytokines production in chronic schizophrenia patients with or without para-noid behaviour //Prog Neuropsychopharmacol Biol Psychiatry.- 1998.- vol. 22, p. 947−957.
- Cazzullo C.L., et al. Research on psychoimmunology //World J Biol Psychiatry.- 2003.- vol. 4, p. 119−123.
- Chelmicka-Schorr E., Arnason B.G. Nervous system-immune system interactions and their role in multiple sclerosis //Ann Neurol.- 1994.-vol. 36 Suppl, p. S29−32.
- Cherkaoui J., et al. The nucleus basalis is involved in brain modulation of the immune system in rats //Brain Res.- 1990.- vol. 516, p. 345−348.
- Connor T J., Leonard B.E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. // Life-Sci. 1998. — v.62, № 7. — P.583−606.
- Corcos M., et al. Cytokines and anorexia nervosa //Psychosom Med.-2001.- vol. 63, p. 502−504.
- Cornet A., et al. Role of astrocytes in antigen presentation and naive T-cell activation /Я Neuro-immunol.- 2000.- vol. 106, p. 69−77.
- Covelli V., Maffione A.B., Nacci C., Tato E., Jirillo E. Stress, neuropsychiatry disorders and immunological effects exerted by benzodiazepines // Immunopharmacol. Immunotoxicol. 1998. May. Vol. 20, № 2. P. 199−209.
- Croiset G., et al. Role of corticotropin-releasing factor, vasopressin and the autonomic nervous sys-tem in learning and memory //Eur J Pharmacol.- 2000.- vol. 405, p. 225−234.
- DeLisi L.E. Critical overview of current approaches to genetic mechanisms in schizophrenia re-search //Brain Res Brain Res Rev.-2000.- vol. 31, p. 187−192.
- Denicoff K.D., et al. The neuroendocrine effects of interleukin-2 treatment //J Clin Endocrinol Me-tab.- 1989.- vol. 69, p. 402−410.
- Dijkstra S., et al. Selective stimulation of dendrite outgrowth from identified corticospinal neurons by homotopic astrocytes //Neuroscience.- 1999.-vol. 92, p. 1331−1342.
- Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity //Eur Psychiatry.- 2002.- vol. 17 Suppl 3, p. 306−310.
- Dunn A.J. Cytokine activation of the HPA axis //Ann N Y Acad Sci.-2000.- vol. 917, p. 608−617.
- Dunn A.J. Effects of the IL-1 receptor antagonist on the IL-1- and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice //Neuroimmunomodulation.- 2000, — vol. 7, p. 36−45.
- Dunn A.J., Swiergiel A.H. The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment //Neuroimmunomodulation.- 2001.- vol. 9, p. 163−169.
- Durkin H.G., Waksman B.H. Thymus and tolerance. Is regulation the major function of the thy-mus? //Immunol Rev.- 2001.- vol. 182, p. 3357.
- Engelhardt В., et al. Involvement of the choroid plexus in central nervous system inflammation //Microsc Res Tech.- 2001.- vol. 52, p. 112−129.
- Farrar W.L., et al. The molecular basis of immune cytokine action //Crit Rev Ther Drug Carrier Syst.- 1989.- vol. 5, p. 229−261.
- Fecho K., et al. Evidence for sympathetic and adrenal involvement in the immunomodulatory ef-fects of acute morphine treatment in rats //J Pharmacol Exp Ther.- 1996.- vol. 277, p. 633−645.
- Fischer H.G., Bielinsky А.К. Antigen presentation function of brain-derived dendriform cells de-pends on astrocyte help //Int Immunol.1999.-vol. 11, p. 1265−1274.
- Flavell R.A., et al. MAP kinases in the immune response //Annu Rev Immunol.- 2002.- vol. 20, p. 55−72.
- Frei K., Fontana A. Antigen presentation in the CNS //Mol Psychiatry.-1997.- vol. 2, p. 96−98.
- Gadient R.A., et al. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes //Neurosci Lett.- 1990.- vol. 117, p. 335−340.
- Ganguli R., et al. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothe-sis //Harv Rev Psychiatry.- 1994.- vol. 2, p. 70−83.
- Gaykema R.P., et al. Bacterial endotoxin induces fos immunoreactivity in primary afferent neu-rons of the vagus nerve //Neuroimmunomodulation.- 1998.- vol. 5, p. 234−240.
- Girvin A.M., et al. Differential abilities of central nervous system resident endothelial cells and as-trocytes to serve as inducible antigen-presenting cells //Blood.- 2002.- vol. 99, p. 3692−3701.
- Goldstein G., et al. Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression //Biol Psychiatry.2000.- vol. 48, p. 65−69.
- Gottschall P.E., Yu X. Cytokines regulate gelatinase A and В (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes //J Neurochem.- 1995.- vol. 64, p. 1513−1520.
- Hanisch U.K. Microglia as a source and target of cytokines //Glia.-2002.- vol. 40, p. 140−155.
- Harbuz M.S., et al. The hypothalamic-pituitary-adrenal axis in autoimmunity //Ann N Y Acad Sci.- 1997.- vol. 823, p. 214−224.
- Hare A.S., et al. Bacterial lipopolysaccharide-induced changes in FOS protein expression in the rat brain: correlation with thermoregulatory changes and plasma corticosterone //J Neuroendocrinol.- 1995, — vol. 7, p. 791−799.
- Hart R.P., et al. Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia //J Neurosci Res.- 1991.- vol. 29, p. 282−291.
- Hecht H., Bronisch T. Major depression with and without a coexisting anxiety disorder: social dys-function, social integration, and personality features //J Affect Disord.- 1990.- vol. 20, p. 151−157.
- Henneberg A., et al. T-lymphocyte subpopulations in schizophrenic patients //Eur Arch Psychiatry Neurol Sci.- 1990.- vol. 239, p. 283−284.
- Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system //Glia.- 2001.- vol. 36, p. 118−124.
- Hinze-Selch D., et al. Clozapine, cytokines, fever and sleep. //Wien Med Wochenschr.- 1996.-vol. 146, p. 311−313.
- Hinze-Selch D., et al. Sleep during clozapine-induced fever in a schizophrenic patient //Biol Psy-chiatry.- 1995.- vol. 38, p. 690−693.
- Hornberg M., et al. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia //Schizophr Res.-1995.- vol. 15, p. 237−242.
- Hsueh C.M., et al. Expression of the conditioned NK cell activity is beta-endorphin dependent //Brain Res.- 1995.- vol. 678, p. 76−82.
- Irwin M., Immune correlates of depression. //Adv Exp Med Biol. -1999−461-p.1−24.
- Jafarian-Tehrani M., et al. Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice //Endocrinology.- 1995.- vol. 136, p. 609−613.
- Johnson A.K., Gross P.M. Sensory сircumventricular organs and brain homeostatic pathways //Faseb J.- 1993.- vol. 7, p. 678−686.
- Jonakait G.M., Hart R.P. Immune cytokine regulation of sympathetic ganglion response to injury //Neuroimmunomodulation.- 1995.- vol. 2, p. 236−240.
- Jonakait G.M., Schotland S. Conditioned medium from activated splenocytes increases substance P in sympathetic ganglia //J Neurosci Res.- 1990.- vol. 26, p. 24−30.
- Joyce P.R., et al. Elevated levels of acute phase plasma proteins in major depression //Biol Psychia-try.- 1992.- vol. 32, p. 1035−1041.
- Kaminska Т., et al. Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics //Med Sci Monit.- 2003.-vol. 9, p. CS71−75.
- Kaminska Т., et al. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients //Arch Immunol Ther Exp (Warsz).- 2001.- vol. 49, p. 439−445.
- Kelley K.W. Cross-talk between the immune and endocrine systems //J Anim Sci.- 1988.- vol. 66, p. 2095−2108.
- Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Psychoneuroimmunology and psychosomatic medicine: back to the future.//Psychosom Med. 2002 — Jan-Feb — 64(1) — p. 15−28.
- Kies M.W., et al. Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic pro-tein //Ann Neurol.- 1989.- vol. 26, p. 342 346.
- Kluger M.J., et al. Cytokines and fever //Neuroimmunomodulation.-1995.- vol. 2, p. 216−223.
- Komorowska-Pietrzykowska R., et al. Interleukin-6, tumor necrosis factor alpha and interferon gamma in patients with anorexia nervosa //Adv Exp Med Biol.- 2001.- vol. 495, p. 173−176.
- Komorowska-Pietrzykowska R., et al. Immunological system activity in anorexia nervosa. //Psychiatr Pol.- 1996.- vol. 30, p. 801−810.
- Kruger K.W. Lupus erythematosus and the central nervous system. //Nervenarzt.- 1984, — vol. 55, p. 165−172.
- Kubera M., et al. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of de-pression //J Affect Disord.- 2001.-vol. 63, p. 171−178.
- Lamour Y., et al. Synaptic functions in the aged rat hippocampus: a target for corticosteroids? //Psychoneuroendocrinology.- 1997.- vol. 22 Suppl 1, p. S69−74.
- Leonard B.E., Changes in the immyne system in depression and dementia: causal or coincidental effects? — Int J Dev Neurosci. — 2001 — 19(3) -p.305−12.
- Leonard. B.E., Song C. Stress, depression, and the role of cytokines //Adv Exp Med Biol.- 1999.- vol. 461, p. 251−265.
- Licinio J., Frost P. The neuroimmune-endocrine axis: pathophysiological implications for the cen-tral nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics //Braz J Med Biol Res.- 2000.- vol. 33, p. 1141−1148.
- Linington C., et al. Identification of an encephalitogenic determinant of myelin proteolipid protein for the rabbit //J Neuroimmunol.- 1990.- vol. 30, p. 135−144.
- Livnat S., et al. Regulation of the immune system by sympathetic neural mechanisms //Prog Neu-ropsychopharmacol Biol Psychiatry.- 1987.-vol. 11, p. 145−152.
- Ludlam W.H., et al. LIF-and IL-1 beta-mediated increases in substance P receptor mRNA in axotomized, explanted or dissociated sympathetic ganglia //Brain Res.- 1995.- vol. 685, p. 12−20.
- Luecken L.J., Lysle D.T. Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation /Я Neuroimmunol.- 1992.- vol. 38, p. 209−219.
- Lysle D.T., et al. Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids //Brain Behav Immun.- 1992.- vol. 6, p. 179−188.
- Madden K.S. Catecholamines, sympathetic innervation, and immunity //Brain Behav Immun.- 2003.- vol. 17 Suppl 1, p. S5−10.
- Maes M. Evidence for an immune response in major depression: a review and hypothesis // Prog. Neuropsychopharmacol. Biol. Psychiatry. 1995. Jan. Vol. 19,№l.P.ll-38.
- Maes M., Bosmans E., Calabrese G. et al. Interleukin-2 and Interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers // J. Psychiatr. Res. 1995. Vol. 29, № 2. P. 142−152.
- Maes M. et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. // Biol. Psychiatry. 1999. — v.45, № 7. — P.833−839.
- Maes M, Vandoolaeghe E., Ranjan R., Bosmans E., Bergmans R., Desnyder R. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. //J. Affect. Dicord. 1995. — v.36, №l-2.-P.29−36.
- Main C., et al. Human recombinant interleukin 1 beta suppresses acetylcholine release from rat myenteric plexus //Gastroenterology.-1993.- vol. 104, p. 1648−1654.
- Mameya S., et al. Arachidonic acid cascade and stimulation of acetylcholine release by human re-combinant interleukin-1 beta in guinea pig ileum //J Pharmacol Exp Ther.- 1995.- vol. 275, p. 319−324.
- Maness P.F. Nonreceptor protein tyrosine kinases associated with neuronal development //Dev Neurosci.- 1992.- vol. 14, p. 257−270.
- Mason P., et al. Somatodendritic morphology of on- and off-cells in the rostral ventromedial me-dulla //J Comp Neurol.- 1990.- vol. 301, p. 2343.
- Matta S., et al. The brain-immune axis: role of opiates and other substances of abuse, the hypotha-lamic-pituitary-adrenal axis and behavior //Adv Exp Med Biol.- 1995.- vol. 373, p. 1−9.
- Matyszak M.K., et al. Microglia induce myelin basic protein-specific T cell anergy or T cell activa-tion, according to their state of activation //Eur J Immunol.- 1999.- vol. 29, p. 3063−3076.
- Matyszak M.K., Perry V.H. The potential role of dendritic cells in immune-mediated inflamma-tory diseases in the central nervous system //Neuroscience.- 1996.- vol. 74, p. 599−608.
- McDaniel J.S., et al. Natural killer cell activity in patients with panic disorder//Anxiety.- 1994.-vol. l, p. 192−195.
- McGlynn T.J., Tinker D.E. Anorexia nervosa in adulthood //Am Fam Physician.- 1989.-vol. 39, p. 173−178.
- Meinl E., et al. Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells //Brain.- 1994.- vol. 117 (Pt 6), p. 1323−1332.
- Mittleman B.B., et al. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease //J Im-munol.- 1997.- vol. 159, p. 2994−2999.
- Monteleone P., et al. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment //J Clin Psychopharmacol.- 2002.- vol. 22, p. 424−426.
- Montgomery S.A. Long-term treatment of depression //Br J Psychiatry Suppl.- 1994.- vol. p. 31−36.
- Muller N., Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. // Prog. Neuropsychopharmacol. Biol. Psychiatry. 1998. — v.22, № 1. — P. 1−33.
- Muller N., Kurtz G. The antiphospholipid syndrome and psychosis //Am J Psychiatry.- 1994.- vol. 151, p. 1841−1842.
- Naudin J., et al. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophre-nia? //Schizophr Res.- 1997.- vol. 26, p. 227 233.
- Naudin J., et al. Elevated circulating levels of IL-6 in schizophrenia //Schizophr Res.- 1996.- vol. 20, p. 269−273.
- Neumann H. Control of glial immune function by neurons //Glia.-2001.-vol. 36, p. 191−199.
- Nguyen V.T., Benveniste E.N. Critical role of tumor necrosis factor-alpha and NF-kappa В in in-terferon-gamma -induced CD40 expression in microglia/macrophages //J Biol Chem.- 2002.- vol. 277, p. 1 379 613 803.
- Niijima A. Reflex effects of oral, gastrointestinal and hepatoportal glutamate sensors on vagal nerve activity //J Nutr.- 2000.- vol. 130, p. 971S-973S.
- Niijima A., et al. Hepato-vagal pathway associated with nicotine’s anorectic effect in the rat //Auton Neurosci.- 2001.- vol. 93, p. 48−55.
- Pashenkov M., et al. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation//J Neuroimmunol.-2003.-vol. 135, p. 154−160.
- Pashenkov M., et al. Inflammation in the central nervous system: the role for dendritic cells //Brain Pathol.- 2003.- vol. 13, p. 23−33.
- Pavol M.A., et al. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia //Neurology.- 1995.- vol. 45, p. 947−950.
- Perry V.H. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease //Brain Behav Immun.- 2004.- vol. 18, p. 407−413.
- Pollmacher Т., et al. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels //Pharmacopsychiatry.-1997.-vol. 30, p. 118−121.
- Pollmacher Т., et al. Effects of antipsychotic drugs on cytokine networks //J Psychiatr Res.- 2000.- vol. 34, p. 369−382.
- Pollmacher Т., et al. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors //Arch Gen Psychiatry.- 1995.-~vol. 52, p. 877−878.
- Pollmacher Т., et al. On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors. //Fortschr Neurol Psychiatr.- 2001.- vol. 69 Suppl 2, p. S65−74.
- Pousset F., et al. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes //J Neurochem.- 2001.- vol. 79, p. 726−736.
- Rabin B.S., et al. Interaction between the brain and the immune system Immunol Ser.- 1990.- vol. 52, p. 125−154.
- Ramesh C., et al. A comparative study of immune status in panic disorder patients and controls //Acta Psychiatr Scand.- 1991.- vol. 84, p. 396−397.
- Rapaport M.H., Stein M.B. Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder //Anxiety.- 1994.- vol. 1, p. 2225.
- Rapaport M.H., et al. Sertraline treatment of panic disorder: results of a long-term study //Acta Psychiatr Scand.- 2001.- vol. 104, p. 289−298.
- Raps A., et al. Relation between schizophrenic-like psychosis and Sjogren syndrome (SS) //Isr J Psychiatry Relat Sci.- 1986, — vol. 23, p. 321−324.
- Ravindran A.V., Griffiths J., Merali Z., Anisman H. Variations of lymphocyte subsets associated with stress in depressive populations. // Psychoneuroendocrinology 1996 v. 21 (8) — p. 659−671.
- Ravindran A.V., Zaharia M.D., Griffiths J., Merali Z., Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. // J. Affect. Disord. 2000. — v.58, № 1.
- Raymond N.C., et al. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity /Ant J Eat Disord.- 2000.- vol. 28, p. 293−302.
- Renoux G. The cortex regulates the immune system and the activities of a T-cell specific im-munopotentiator //Int J Neurosci.- 1988.- vol. 39, p. 177−187.
- Riekkinen P., Sr. Neurological research today. //Duodecim.- 1997.-vol. 113, p. 1721−1726.
- Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis //Psychoneuroendocrinology.- 2001.- vol. 26, p. 761−788.
- Roitt I. et al Immunology.6 Ed. //- Harcourt Publishers Limited June 200IK — 496 pages — ISBN: 723 431 892
- Rudolf S., et al. The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro //Neuropsychobiology.- 2002.- vol. 46, p. 180−185.
- Ruhl A., et al. Interleukin-6 expression and regulation in rat enteric glial cells //Am J Physiol Gas-trointest Liver Physiol.- 2001.- vol. 280, p. G1163−1171.
- Sanders V.M., et al. Adaptive immunity in mice lacking the beta-adrenergic receptor //Brain Behav Immun.- 2003.- vol. 17, p. 55−67.
- Saunders B.P., Trewby P.N. The neuroleptic malignant syndrome: a missed diagnosis? //Br J Clin Pract.- 1993, — vol. 47, p. 170−171.
- Schauenstein K., et al. The dialogue between the brain and immune system involves not only the HPA-axis //Z Rheumatol.- 2000.- vol. 59 Suppl 2, p. 11/49−53.
- Schauenstein K., et al. Mens sana in corpore sano—and vice versa. The role of the autonomic nerv-ous system in the immune-neuroendocrine dialogue //Int J Hyg Environ Health.- 2001.- vol. 204, p. 75−79.
- Schleifer S.J., et al. Panic disorder and immunity: few effects on circulating lymphocytes, mitogen response, and NK cell activity //Brain Behav Immun.- 2002.- vol. 16, p. 698−705.
- Schleuning M., Munker R. Tumor necrosis factor: an update on basic research and clinical appli-cations //Klin Wochenschr.- 1990.- vol. 68, p. 841−846.
- Schobitz В., et al. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain //Prog Neurobiol.-1994.- vol. 44, p. 397−432.
- Schuld A., et al. Granulocyte colony-stimulating factor plasma levels during clozapine- and olan-zapine-induced granulocytopenia //Acta Psychiatr Scand.- 2000.- vol. 102, p. 153−155.
- Schwarz M.J., et al. T-helper-1 and T-helper-2 responses in psychiatric disorders //Brain Behav Immun.- 2001.- vol. 15, p. 340−370.
- Shanks N., et al. Time-dependent variations of central norepinephrine and dopamine following antigen administration //Brain Res.- 1991.- vol. 557, p. 69−76.
- Shiozawa S., et al. Interferon-alpha in lupus psychosis //Arthritis Rheum.- 1992.- vol. 35, p. 417−422.
- Shuto H., et al. Inhibition of GABA system involved in cyclosporine-induced convulsions //Life Sci.- 1999.- vol. 65, p. 879−887.
- Shuto H., et al. Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain //Brain Res.- 1997.-vol. 747, p. 348−351.
- Singh V.K., Jensen R.L. Elevated levels of measles antibodies in children with autism //Pediatr Neurol.- 2003.- vol. 28, p. 292−294.
- Siuciak J.A., et al. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain //J Neurosci Res.- 1998.- vol. 52, p. 149−158.
- Siuciak J.A., et al. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF) //Pharmacol Biochem Behav.- 1997.- vol. 56, p. 131−137.
- Skurkovich В., Skurkovich S. Anti-interferon-gamma antibodies in the treatment of autoimmune diseases //Curr Op in Mol Ther.- 2003.- vol. 5, p. 52−57.
- Skurkovich S.V., et al. Improvement in negative symptoms of schizophrenia with antibodies to tumor necrosis factor-alpha and to interferon-gamma: a case report //J Clin Psychiatry.- 2003.- vol. 64, p. 734−735.
- Sluzewska A. Indicators of immune activation in depressed patients //Adv Exp Med Biol.- 1999.- vol. 461, p. 59−73.
- Smith R.S. A comprehensive macrophage-T-lymphocyte theory of schizophrenia//Med Hy-potheses.- 1992.- vol. 39, p. 248−257.
- Smith R.S. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 re-ceptors by gastrointestinal lymphocytes? //Med Hypotheses.- 1991.- vol. 34, p. 225−229.
- Solvason H.B., et al. A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model //Int J Neurosci.- 1991.- vol. 61, p. 277−288.
- Solvason H.B., et al. A simple, single, trial-learning paradigm for conditioned increase in natural killer cell activity //Proc Soc Exp Biol Med.- 1992.-vol. 199, p. 199−203.
- Sommer R., Dewar R. Views of a mental hospital //Ment Hyg.- 1962.-vol. 46, p. 238−248.
- Sommer R., Osmond H. The schizophrenic no-society //Psychiatry.-1962.- vol. 25, p. 244−255.
- Spring B. Stress and schizophrenia: some definitional issues //Schizophr Bull.- 1981.- vol. 7, p. 24−33.
- Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease //J Endocrinol.- 2001.- vol. 169, p. 429−435.
- Sternberg E.M., et al. The stress response and the regulation of inflammatory disease //Ann Intern Med.- 1992.- vol. 117, p. 854−866.
- Stitt J.T. Passage of immunomodulators across the blood-brain barrier //Yale J Biol Med.- 1990.- vol. 63, p. 121−131.
- Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS //Glia.- 2002.- vol. 40, p. 133−139.
- Stubbs G. Interferonemia and autism //J Autism Dev Disord.- 1995.-vol. 25, p. 71−73.
- Sundar S.K., et al. Brain IL-1-induced immunosuppression occurs through activation of both pitui-tary-adrenal axis and sympatheticnervous system by corticotropin-releasing factor //J Neurosci.- 1990.-vol. 10, p. 3701−3706.
- Surman O.S., et al. Immunological response to stress in agoraphobia and panic attacks //Biol Psy-chiatry.- 1986.- vol. 21, p. 768−774.
- Suzuki K., Koyama T. Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs. //Ryoikibetsu Shokogun Shirizu.-2003.- vol. p. 366−369.
- Takayama K., et al. Gene therapy for lung cancer treatment. //Nippon Rinsho.- 2000.- vol. 58, p. 1048−1052.
- Tazi A., et al. Potentiation of behavioural effects of a calcium channel antagonist, nifedipine, by ipsapirone //Behav Pharmacol.- 1992.- vol. 3, p. 269−273.
- Van Dam A.M., et al. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study //Neuroscience.- 1995.- vol. 65, p. 815−826.
- Von Bertalanffy L. //General system theory: foundations, development, applica-tions. N. Y., G. Braziller, — 1968. — 289
- Walker W.S., et al. Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells //J Neuro-immunol.- 1995.- vol. 63, p. 163−174.
- Wank R. Schizophrenia and other mental disorders require long-tern adoptive immunotherapy. Med Hypotheses. 2002 Aug- 59(2): 154.
- Watkins L.R., Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states //Physiol Rev.- 2002.-vol. 82, p. 981−1011.
- Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain //J Intern Med.-2005.- vol. 257, p. 139−155.
- Weber F., et al. Human myelin basic protein specific T cell lines display differential cytotoxicity against astrocytes, but are consistently cytotoxic against monocytes //J Neuroimmunol.- 1998.- vol. 88, p. 99−104.
- Weber F., et al. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis //Brain.- 1994.- vol. 117 (Pt 1), p. 59−69.
- Weber R.J., et al. Neural control of immune function: opioids, opioid receptors and immunosup-pression //NIDA Res Monogr.- 1991.- vol. 105, p. 96−102.
- Weizman R., et al. Cytokine production in obsessive-compulsive disorder //Biol Psychiatry.- 1996.- vol. 40, p. 908−912.
- Wetmore D.Z., Baker S.N. Post-spike distance-to-threshold trajectories of neurones in monkey motor cortex //J Physiol.- 2004.- vol. 555, p. 831−850.
- Wilke I., et al. Investigations of cytokine production in whole blood cultures of paranoid and resid-ual schizophrenic patients //Eur Arch Psychiatry Clin Neurosci.- 1996.- vol. 246, p. 279−284.
- Wolf S.A., et al. Neuroprotection by T-cells depends on their subtype and activation state //J Neuroimmunol.- 2002.- vol. 133, p. 72−80.
- Zalcman S., et al. Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system //J Pharmacol Exp Ther.- 1994.- vol. 271, p. 977−982.
- Zalcman S., et al. Interleukin-6 increases sensitivity to the locomotor-stimulating effects of am-phetamine in rats //Brain Res.- 1999.- vol. 847, p. 276−283.
- Zarrabi M.H., et al. Immunologic and coagulation disorders in chlorpromazine-treated patients //Ann Intern Med.- 1979.- vol. 91, p. 194−199.
- Zinetti M., et al. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro immunology.- 1995.- vol. 86, p. 416−421.
- Zubin J., Ludwig A.M. What is schizophrenia? //Schizophr Bull.- 1983.-vol. 9, p. 331−335.